Understanding Acute on Chronic Renal Failure (also known as Acute on Chronic Kidney Failure or Acute Kidney Injury on Chronic Kidney Disease) is crucial for accurate clinical documentation and medical coding. This page provides information on diagnosing, documenting, and coding Acute on Chronic Renal Failure for healthcare professionals, focusing on key clinical indicators and best practices for clear and compliant medical records. Learn about Acute Kidney Injury superimposed on Chronic Kidney Disease and its impact on patient care.
Sudden worsening of kidney function in a patient with pre-existing chronic kidney disease.
Decreased urine output, swelling, fatigue, shortness of breath, nausea, confusion.
Hospitalization due to infection, dehydration, heart failure, or nephrotoxic medications.
Complete code families applicable to N17.9
| Description | When to use |
|---|---|
| Sudden worsening of chronic kidney disease. | Use when acute kidney injury develops in a patient with pre-existing chronic kidney disease. |
| Gradual loss of kidney function over time. | Use for long-term kidney damage, stages 1-5, not acute. |
| Sudden loss of kidney function. | Use for rapid decline in kidney function without prior chronic disease. |
Coding acute on chronic renal failure requires clear documentation of both acute and chronic components. Unspecified acuity may lead to downcoding.
Proper coding necessitates specifying the underlying chronic kidney disease stage. Missing stage impacts reimbursement and quality metrics.
Documenting the cause of the acute exacerbation is crucial for accurate coding and may affect severity and DRG assignment.
Verify baseline creatinine reflecting CKD.
Confirm acute worsening of kidney function.
Document cause of acute deterioration.
Check for medications impacting kidney function.
Review fluid balance and electrolyte levels.
Patient presents with acute on chronic renal failure (also known as acute kidney injury on chronic kidney disease), manifested by a recent decline in renal function superimposed on pre-existing chronic kidney disease. The patient's current symptoms include [specific symptoms e.g., decreased urine output, edema, fatigue, shortness of breath, nausea, confusion]. Relevant laboratory findings demonstrate an elevated serum creatinine and blood urea nitrogen (BUN) above the patient's baseline, indicating worsening kidney function. The patient's estimated glomerular filtration rate (eGFR) has further declined, corroborating the diagnosis. Past medical history is significant for [underlying CKD etiology e.g., diabetic nephropathy, hypertensive nephrosclerosis, polycystic kidney disease] and [relevant comorbidities e.g., hypertension, diabetes, cardiovascular disease]. Current medications include [list medications including those potentially nephrotoxic]. Physical examination reveals [relevant physical findings e.g., fluid overload, signs of uremia]. Differential diagnoses considered include prerenal azotemia, acute tubular necrosis, and obstructive uropathy. Initial management includes [initial treatment strategies e.g., fluid management, electrolyte correction, medication adjustments, dialysis if indicated]. Plan for ongoing monitoring of renal function, electrolyte levels, and fluid balance. Further investigations to determine the precipitating factors for the acute deterioration are underway, including [planned investigations e.g., urine analysis, renal ultrasound, review of medications]. Patient education provided on acute on chronic renal failure management, dietary restrictions, and medication adherence. Referral to nephrology for ongoing care and evaluation for renal replacement therapy if indicated.
Differentiating acute on chronic renal failure (ACRF) from a simple exacerbation of chronic kidney disease (CKD) requires a thorough clinical evaluation. Look for a relatively rapid decline in kidney function, often marked by a significant rise in serum creatinine over days to weeks, beyond the usual trajectory of CKD progression. Consider factors like recent medication changes (e.g., nephrotoxic drugs), intercurrent infections, volume depletion, or obstructive uropathy, which can precipitate ACRF. Careful review of the patient's baseline kidney function trends is crucial. Furthermore, urine microscopy can offer clues, with findings like muddy brown casts suggesting acute tubular necrosis, a common contributor to ACRF. Explore how combining clinical presentation, laboratory findings, and patient history can lead to a more accurate diagnosis and tailored management of ACRF. Consider implementing a standardized protocol in your practice for evaluating rapid declines in kidney function to ensure prompt recognition and management of ACRF.
Managing acute kidney injury (AKI) superimposed on chronic kidney disease (CKD), often referred to as acute on chronic renal failure, necessitates a multi-faceted approach. First, identify and address the underlying cause of the AKI, such as infection, medication toxicity, or volume depletion. Optimize fluid balance, carefully considering the patient's CKD status and potential for fluid overload. Closely monitor electrolyte levels, especially potassium and phosphorus, and adjust as needed. Review current medications and discontinue potentially nephrotoxic agents. Renal replacement therapy, such as dialysis, may be necessary depending on the severity of the AKI and the presence of life-threatening complications like hyperkalemia or pulmonary edema. Learn more about the specific indications for dialysis in ACRF and the different modalities available. Close monitoring of kidney function and electrolyte levels during and after the acute phase is essential to guide ongoing management. Consider implementing a multidisciplinary approach involving nephrology, pharmacy, and other specialties as needed for optimal patient outcomes.
Acute on chronic kidney failure (ACKF) carries a worse prognosis compared to either acute kidney injury or chronic kidney disease alone. Patients with ACKF are at increased risk for faster progression to end-stage renal disease (ESRD), cardiovascular events, and increased mortality. Long-term complications include persistent renal dysfunction, electrolyte imbalances, mineral bone disorders, and anemia. Mitigating these risks involves prompt and aggressive management of the acute insult, meticulous control of blood pressure, and optimization of CKD management strategies. This includes appropriate use of renin-angiotensin-aldosterone system inhibitors, management of anemia and mineral bone disease, and patient education on lifestyle modifications. Consider implementing a comprehensive care plan that addresses both the acute and chronic aspects of ACKF to improve long-term outcomes. Explore how a collaborative approach between primary care physicians and nephrologists can optimize care for patients with ACKF and potentially slow the progression to ESRD.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.